|
November 1, 2011
By:
Jennifer Ringler, Ben Comer
Over 25 years the Rx Club Show has reflected dramatic technological changes in advertising. But, as always, the subject comes first, the medium second. So where did the accolades go this year?
|
October 1, 2011
30 Years of Pharma: Perspective in Numbers
|
|
October 1, 2011
By:
Jennifer Ringler
The rise of advocacy groups has helped patients find their voice, but the power to change health profiles remains an elusive goal.
|
October 1, 2011
By:
Jill Wechsler
Henry Waxman, Congressional Representative from Los Angeles, California
|
October 1, 2011
By:
Ben Comer
Josef von Rickenbach, President & CEO, Parexel
|
October 1, 2011
Fred Frank, Vice Chairman, P.J. Solomon Co.
|
August 1, 2011
By:
Ted Prusik
In medicines, as in life, the journey is just as important as the end result
|
November 1, 2008
By:
Brittany Agro
Top Rx Club Award winners exhibit qualities that ironically juxtapose industry's paradigm (pdf)
|
December 1, 2007
By:
Joanna Breitstein
Science is the lifeblood of pharma, of course. But these days, science isn't just what you produce in your own labs. It's what you can license, buy, partner on, or gain through acquisition. Which means that, increasingly, deals are the lifeblood of pharma.
|
|
PharmExec Blog
Follow Us
RSS
Bookstore
